Kevin Mcculloch
See Remarks at Xeris Biopharma Holdings, Inc. (XERS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 15,0001,599,208 held (−1%) | $9.41 | $141K | +11.4% |
| Sep 29SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 25,0001,614,208 held (−2%) | $10.00 | $250K | +4.8% |
| Sep 1SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 15,0001,639,208 held (−1%) | $8.49 | $127K | +23.4% |
| Aug 4SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 15,0001,676,126 held (−1%) | $8.02 | $120K | +30.7% |
| Jul 2SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 90,0001,691,126 held (−5%) | $8.03 | $723K | +30.5% |
| Jan 9SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 15,0001,685,426 held (−1%) | $8.00 | $120K | +31.0% |
- Sell
See Remarks Kevin Mcculloch sold $141K of XERS at $9.41 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Kevin Mcculloch sold $250K of XERS at $10.00 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Kevin Mcculloch sold $127K of XERS at $8.49 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Kevin Mcculloch sold $120K of XERS at $8.02 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Kevin Mcculloch sold $723K of XERS at $8.03 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Kevin Mcculloch sold $120K of XERS at $8.00 — pre-scheduled 10b5-1 plan sale.